Time spent on rituximab infusion and its impact on patient and caregiver burden

AMCP-2

Understanding patient perspectives regarding rituximab administration is important as stakeholders make decisions between intravenous (IV) and the recently-approved subcutaneous method of administration. Most patients reported that time-reduction would have a positive impact on their life. Understanding the patient's perspective and overall time burden of rituximab administration will benefit clinical decision-making and quality of care.